Short answer
Annexon, Inc. (ANNX) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Muneer Satter resigned immediately before successor appointment after more than 11 years, with no operational, policy, or strategy disagreement.
Annexon, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Muneer Satter resigned immediately before successor appointment after more than 11 years, with no operational, policy, or strategy disagreement
- Mark S. Blumenkranz appointed Class II director through 2028 annual meeting, adding ophthalmology expertise to the Board
- Blumenkranz joins Audit Committee and Science and Technology Committee
- Director compensation includes $40,000 annual retainer and options for 65,000 shares annually
- Initial 175,000-share stock option granted under the 2020 Incentive Award Plan
Item 7.01 · Regulation FD Disclosure
- Board transition: Mr. Satter resigned and Dr. Blumenkranz was appointed
- Governance change may affect strategic oversight and investor confidence
- Press release dated August 10, 2026 provides additional background on the appointments
Item EX-99.1 · Exhibit EX-99.1
- Board adds Mark S. Blumenkranz, retinal specialist and biotechnology entrepreneur with over four decades of industry experience
- Appointment strengthens strategic expertise for vonaprument’s geographic atrophy program and potential commercialization
- Muneer Satter steps down after more than 11 years as director and investor
- Vonaprument advancing toward pivotal Phase 3 data and potential registration
- Executive commentary remains forward-looking, with approval, financing, clinical, manufacturing and commercialization risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Annexon, Inc. 8-K filings
Get the next ANNX 8-K as it lands
Follow ANNX for push alerts, or ask the research agent what this filing means.